Avigi aims to inhibit Heparanase. Why heparanase? This enzyme plays a key role in tissue remodeling, cancer metastasis, and inflammatory diseases, making it a prime target for therapeutic intervention. Inspired by nature’s own molecules, our team engineered a disaccharide-inspired inhibitor capable of selectively halting heparanase activity without disrupting healthy cellular processes.

Installing solar-powered wells in Tanzania with a team of students

OPAL is on a mission to empower individuals and organizations to unlock their full potential by harmonizing work and rest through innovative, human-centric lighting (HCL) solutions. Did you know that most of us live in a biological state of darkness, leading to sub-optimal productivity, mood, and sleep? This presentation will explore the science behind salutogenics, biophilic design, HCL and how OPAL is turning these insights into a scalable business that bridges well-being and performance. Join us to discover how light can transform the way we live and work.